Hadassah

ALS Stem Cell Trial Yielding “Impressively Positive” Findings

Thursday, Jan 2 2014

Commenting on the Phase IIa trial of NurOwn™--BrainStorm Cell Therapeutics' stem cell therapy for amyotrophic lateral sclerosis (ALS)--which is being conducted at the Hadassah Medical Organization, Prof. Dimitrios Karussis, principal investigator, reports that the safety data are "impressively positive" and that the "initial indications of clinical efficacy" are cause for optimism regarding the management of ALS and the future of cell therapies for neurodegenerative diseases in general.

Prof. Karussis, Neurologist and Director of the Multiple Sclerosis Center at Hadassah, presented some of his preliminary findings from this ongoing dose-escalating trial at the 24th International Symposium on ALS/MND in Milan, Italy. MND, Motor Neuron Disease, is the name given to a group of diseases in which the nerve cells (neurons) that control muscles undergo degeneration and die.

According to Prof. Karussis, although the final data are not yet available for publication because the trial is still ongoing, researchers have met with only minimal and transient adverse effects, even though the patients in the study were given the treatment both intrathecally (into the cerebrospinal fluid by injection into the subarachnoid space of the spinal cord) and intramuscularly, with up to double the dose of the stem cells given in the Phase I trial.

At the conclusion of the clinical trial, BrainStorm will release the complete set of data and corresponding analyses.

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Thursday, Feb 21 2019

Hadassah Heart Specialist Performs Revolutionary Repair of Fatal Aortic Condition

Most people with aneurysms have to choose between very risky surgery or waiting for their aneurysm to rupture. Now there’s a new method to repair the deadly medical condition.

READ MORE ›
alt_text

Wednesday, Feb 20 2019

Jerusalem Basketball Star Undergoes Knee Surgery at Hadassah

Chris Johnson, a star basketball player with Hapoel Bank Yahav Jerusalem, underwent successful knee surgery at Hadassah Hospital Mount Scopus.

READ MORE ›
alt_text

Tuesday, Feb 19 2019

Marathoner Is Helicoptered to Hadassah After Collapsing During Race

Shahar David, age 46, had planned to run 10 kilometers in the Dead Sea Marathon, but he collapsed after kilometer 6. A helicopter transported him to Hadassah Hospital Ein Kerem, where he underwent an emergency cardiac catheterization that saved his life.

READ MORE ›
alt_text

Thursday, Feb 7 2019

Six Miscarriages, a Severe Liver Disease, and a Dream

Oshrat Ohana Nagar was a busy newspaper journalist, a self-proclaimed workaholic, and a mother of two children. Shortly after the birth of her second child, however, she began to experience pain throughout her body.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More